Oct. 6 at 5:58 PM
$MAXHEALTH.NSE
बहतर सेहत, बेहतरीन निवेश—MAXHEALTH शेयर के साथ सुरक्षित भविष्य की ओर बढ़ें।
Technical View — Daily Chart
$MAX Healthcare formed a wide-range bullish reversal candle today after opening at ₹1,107.90, making an intraday low of ₹1,101.80 and a high of ₹1,148.10 before closing at ₹1,143.20, which signals strong intraday buying and short-covering.
$PRICE is now holding above the 14 day EMA and the ₹1,135 horizontal support, with RSI rebounding from sub 50 toward the mid 50s and daily MACD histogram flattening (still negative), suggesting a short term mean reversion attempt rather than a confirmed trend reversal.
Key intraday/near term levels: support ₹1,135 (14 day EMA) and ₹1,120 (stopwatch support); immediate resistance ₹1,190–₹1,200 and higher resistance cluster near the 50 DMA around ₹1,240–1,260.
Volume/structure note: Today’s
$RANGE expansion on higher volumes relative to the prior down days supports the probability of a follow through; look for sustained volume above the 10 day average to validate continuation.
Trade plan (actionable)
Short term trading (speculative): Buy on dips ₹1,135–1,140; Stop loss ₹1,120; Targets ₹1,190 (first) and ₹1,200 (stretch). Scale out 50% at first target.
Intraday setup: Long above intraday high ₹1,148 on momentum with tight trailing stop below the 14 EMA.
Positional/Investors: Prefer staggered accumulation (SIP style) or wait for consolidation above ₹1,200 to reduce valuation risk.
Short / Medium / Long term technical bias
Short term (days–weeks): Constructive if ₹1,135 holds; expect 1,190–1,200 in a follow through scenario.
Medium term (weeks–months): Neutral to cautious; stock still below longer moving averages, needs a higher high and higher low confirmation.
Long term (12+ months): Positive business case but technical confirmation required — watch monthly close relative to the 50 and 100 month smoothing for structural turn.
Upcoming News / Events & Likely Impact
•CGHS Rate Revision: Government revised CGHS package rates across ~2,000 procedures (effective mid October window), boosting realization outlook for hospital chains handling CGHS cases; market reacted positively to this sectoral tailwind and it is a near term revenue/margin catalyst.
•Earnings / Board dates: Monitor next quarterly updates and management commentary on occupancy, ARPOB, and guidance — any upside surprise can trigger strong moves; a miss may cause sharp re-rating because of current high multiples.
•Other events to watch: policy updates on insurance reimbursements, NABH/NABL accreditations, and major tie-ups with insurers or govt schemes which can affect volumes and collections.
Disclosure & Disclaimer
This note is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Market and stock prices may be volatile; investors should perform their own due diligence or consult a registered financial adviser before taking any position. Past performance is not an indicator of future returns. Data and news references are taken from public sources and brokerage reports (news articles and company filings) available as of the date of this note. No position in Max Healthcare is held at the time of writing.
